Bioassay Bioinformatics DNA Life Science 
Drug Discovery World
NOVEMBER 30, 2023
It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’. To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7 kb Influenza A hemagglutinin gene was used as a model system.
Drug Discovery World
NOVEMBER 9, 2023
Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. Marine Houdou, Genetic Engineering Specialist, Polyplus, on: ‘From modular DNA assembly to recombinant protein production at Polyplus’. Crystal Richardson, Ph.D, Patrick Doonan, Ph.D.,
Expert insights. Personalized for you.
59 
Let's personalize your content